Nortriptyline

This classification denotes a tricyclic antidepressant with the molecular formula C19H21N, a preparation that US FDA regulates as an active ingredient or moiety under Unique Ingredient Identifier BL03SY4LXB, chemically known as 10,11-dihydro-n-methyl-5h-dibenzo(a,d)cycloheptene-delta(5,gamma)-propylamine but generally known as nortriptyline, which bears US NIH Compound Identifier 4543. European Medicines Agency schedules Nortriptyline in its eXtended EudraVigilance Medicinal Product Dictionary or XEVMPD under Index SUB09380MIG. The term NORTRIPTYLINE is an International Non-Proprietary Name or INN (see WHO INN reference publication, Volume 19 1975, List 5). World Health Organization schedules nortriptyline in its Anatomical Therapeutic Chemical (ATC) Classification. NORTRIPTYLINE is scheduled in the U.S. International Trade Commission's Harmonized Tariff System (HTS) Pharmaceutical Appendix. Most nations schedule nortriptyline under HS 29214980 and SITC 51454. As of Q4 2014, NORTRIPTYLINE remains the US FDA Preferred Term for this commodity. Nortriptyline bears US NLM identifiers UMLS ID C0028420 and NCI Concept Code C62060. SMILES: N(CC/C=C1\c2c(CCc3c1cccc3)cccc2)C.